Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

8 results
Display

Clinical Characteristics of Primary Peritoneal Carcinoma

Roh SY, Hong SH, Ko YH, Kim TH, Lee MA, Shim BY, Byun JH, Woo IS, Kang JH, Hong YS, Lee KS

  • KMID: 2166098
  • Cancer Res Treat.
  • 2007 Jun;39(2):65-68.
PURPOSE: The goal of this study was to determine the clinical and therapeutic characteristics of women with a primary peritoneal carcinoma (PPC). MATERIALS AND METHODS: A retrospective clinical study was conducted...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Detection of Lung Cancer using MAGE A1-6 and SSX4 RT-PCR Expression Profiles in the Bronchial Wash Fluid

Lee KH, Shin KC, Lee CH, Jheon SH, Jeon CH

  • KMID: 2166099
  • Cancer Res Treat.
  • 2007 Jun;39(2):69-73.
PURPOSE: Bronchial wash fluid may be a useful for detecting lung cancer. To increase the detection rates, we performed molecular analysis with using MAGE A1-6 and SSX4 RT-PCR on bronchial...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Differences in Overall Survival When Colorectal Cancer Patients are Stratified into New TNM Staging Strategy

Oh HS, Chung HJ, Kim HK, Choi JS

  • KMID: 2166097
  • Cancer Res Treat.
  • 2007 Jun;39(2):61-64.
PURPOSE: The purpose of this study is to determine whether the prognosis can be more precisely gauged by the revised 6th AJCC staging system and if this is suitable for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
An Attempt for Combining Microarray Data Sets by Adjusting Gene Expressions

Kim KY, Kim SH, Ki DH, Jeong J, Jeong HJ, Jeung HC, Chung HC, Rha SY

  • KMID: 2166100
  • Cancer Res Treat.
  • 2007 Jun;39(2):74-81.
PURPOSE: The diverse experimental environments in microarray technology, such as the different platforms or different RNA sources, can cause biases in the analysis of multiple microarrays. These systematic effects present...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Organizing Pneumonia Associated with Rituximab

Maeng CH, Chin SO, Yang BH, Kim SY, Youn HJ, Cho KS, Baek SK, Lee S

  • KMID: 2166102
  • Cancer Res Treat.
  • 2007 Jun;39(2):88-91.
Rituximab is a human/murine chimeric anti-CD20 mono- clonal antibody used to treat CD20-positive B-cell non- Hodgkin's lymphoma (NHL). Although most of the adverse effects associated with rituximab are usually reversible...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Phase II Study of Docetaxel and Cisplatin as First-line Chemotherapy in Patients with Recurrent or Metastatic Gastric Cancer

Kim KH, Jeung KJ, Kim HJ, Bae SB, Kim CK, Lee NS, Lee KT, Park SK, Won JH, Hong DS, Park HS

  • KMID: 2166095
  • Cancer Res Treat.
  • 2007 Jun;39(2):49-53.
PURPOSE: Palliative chemotherapy for patients with recurrent or metastatic gastric cancer has been shown to have a survival benefit. Docetaxel monotherapy has achieved appreciable results for treating gastric cancer. We...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Chemopreventive Effect of Retinoids on Cellular NF-kappa B Activity Induced by NMU and NEU in Human Malignant Keratinocytes

Moon KY

  • KMID: 2166101
  • Cancer Res Treat.
  • 2007 Jun;39(2):82-87.
PURPOSE: Retinoids have been shown to be effective in suppressing tumor development when chemical carcinogens such as N-nitroso-N-methylurea (NMU) and N- nitroso-N-ethylurea (NEU) were used to induce mammary tumors in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Autologous Stem Cell Transplantation using a Modified TAM Conditioning Regimen for Clinically Aggressive Non-Hodgkin's Lymphoma

Hong SH, Hong YS, Woo IS, Koh YH, Rho SY, Peak JY, Lee MA, Shim BY, Byun JH, Park JC, Lee JW, Min WS, Kim CC

  • KMID: 2166096
  • Cancer Res Treat.
  • 2007 Jun;39(2):54-60.
PURPOSE: High-dose chemotherapy (HDT) and autologous stem cell transplantation (ASCT) have been used for the treatment of clinically aggressive non-Hodgkin's lymphoma (NHL). However, the superiority of specific conditioning regimens has...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr